IBD therapies raise skin cancer risk 17 May 2012 0 comments IBD patients are more likely to develop skin cancer than the general population, with added risk due partly to immunosuppressive medications, a large retrospective cohort study has shown.
Probiotics cut antibiotic related diarrhoea 9 May 2012 0 comments Taking probiotics significantly reduces the risk of developing diarrhoea following antibiotic use, a new review suggests.
Fewer complications with minimally invasive oesophagectomy 2 May 2012 0 comments Oesophageal cancer patients have almost three times fewer pulmonary complications if they undergo minimally invasive oesophagectomy rather than the more conventional open surgery, according to a…
Botox heals anal fissures in bariatric patients 14 Mar 2012 0 comments Botox can bring relief to patients who have undergone biliopancreatic diversion and suffer from anal fissures as a result, an Italian trial has shown.
Exercise lowers NAFLD risk 14 Mar 2012 0 comments Even small amounts of exercise well under recommended levels can lessen the risk of NAFLD, and the effect is independent of weight loss, an Australian meta-analysis has shown.
Location predicts cancer risk in Barrett’s oesophagus 7 Mar 2012 0 comments Over half of high-grade dysplasia and early cancer in short-segment Barrett’s oesophagus occurs in just one quarter of the oesophageal circumference area, according to new Australian research its…
Emu oil: good for the gut? 7 Mar 2012 0 comments Emu oil could be effective in treating inflammatory gastrointestinal diseases such as ulcerative colitis or Chrohn’s, an Australian review has found.
NBI no better for adenoma detection 29 Feb 2012 0 comments Narrow-band imaging is not significantly better at detecting adenomas or polyps than conventional colonoscopy, an Australian meta-analysis has shown.
5-ASA combination best for ulcerative colitis 8 Feb 2012 0 comments A combined oral and topical 5-aminosalicylates (5-ASA) regimen is more effective than oral treatment alone in inducing remission of ulcerative colitis (UC), a new meta-analysis shows.
New tool predicts GIST outcomes 7 Dec 2011 0 comments Most gastrointestinal stromal tumour patients are cured by surgery alone and do not benefit from adjuvant imatinib therapy.